120 related articles for article (PubMed ID: 38331088)
1. Arginine methylation-dependent cGAS stability promotes non-small cell lung cancer cell proliferation.
Liu X; Zheng W; Zhang L; Cao Z; Cong X; Hu Q; Hou J; Jin X; Yuan Q; Lin L; Tan J; Lu J; Zhang Y; Zhang N
Cancer Lett; 2024 Apr; 586():216707. PubMed ID: 38331088
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
[TBL] [Abstract][Full Text] [Related]
3. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
Liu H; Chen X; Wang P; Chen M; Deng C; Qian X; Bai J; Li Z; Yu X
Cell Death Dis; 2024 Feb; 15(2):170. PubMed ID: 38402202
[TBL] [Abstract][Full Text] [Related]
4. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.
Elakoum R; Gauchotte G; Oussalah A; Wissler MP; Clément-Duchêne C; Vignaud JM; Guéant JL; Namour F
Biochimie; 2014 Feb; 97():210-8. PubMed ID: 24211191
[TBL] [Abstract][Full Text] [Related]
5. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
6. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
7. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
[TBL] [Abstract][Full Text] [Related]
8. USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl.
He Y; Jiang S; Zhong Y; Wang X; Cui Y; Liang J; Sun Y; Zhu Z; Huang Z; Mao X
Clin Transl Med; 2023 Dec; 13(12):e1509. PubMed ID: 38082439
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
[TBL] [Abstract][Full Text] [Related]
10. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
11. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
Li M; An W; Xu L; Lin Y; Su L; Liu X
J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
[TBL] [Abstract][Full Text] [Related]
12. Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.
Ma D; Yang M; Wang Q; Sun C; Shi H; Jing W; Bi Y; Shen X; Ma X; Qin Z; Lin Y; Zhu L; Zhao Y; Cheng Y; Han L
Sci Adv; 2021 Mar; 7(13):. PubMed ID: 33762328
[TBL] [Abstract][Full Text] [Related]
13. PRMT1 in human neoplasm: cancer biology and potential therapeutic target.
Shen S; Zhou H; Xiao Z; Zhan S; Tuo Y; Chen D; Pang X; Wang Y; Wang J
Cell Commun Signal; 2024 Feb; 22(1):102. PubMed ID: 38326807
[TBL] [Abstract][Full Text] [Related]
14. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.
Herrmann F; Lee J; Bedford MT; Fackelmayer FO
J Biol Chem; 2005 Nov; 280(45):38005-10. PubMed ID: 16159886
[TBL] [Abstract][Full Text] [Related]
16. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.
Weber S; Maass F; Schuemann M; Krause E; Suske G; Bauer UM
Genes Dev; 2009 Jan; 23(1):118-32. PubMed ID: 19136629
[TBL] [Abstract][Full Text] [Related]
17. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
Yoshimatsu M; Toyokawa G; Hayami S; Unoki M; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):562-73. PubMed ID: 20473859
[TBL] [Abstract][Full Text] [Related]
19. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
[TBL] [Abstract][Full Text] [Related]
20. The role of protein arginine-methyltransferase 1 in gliomagenesis.
Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
